Abas Mahammed¹*, Ziad Abdilahi² and Mohammed Arab³

¹Department of Medical Laboratory Sciences, College of Health and Medical Science, Jigjiga University, Jigjiga, Ethiopia

*Corresponding Author: Abas Mahammed, Department of Medical Laboratory Sciences, College of Health and Medical Science, Jigjiga University, Jigjiga, Ethiopia.

Received: September 17, 2020; Published: May 18, 2022

Abstract

Dengue fever is a mosquito born viral disease emerging as a global public health threat in many parts of the world. Dengue is among one of the arbo-viral diseases, included in the list of neglected tropical diseases, recommended by World Health Organization. Dengue fever remains to be a major health problem in tropical and subtropical areas. In Ethiopia, Dengue Fever is a newly emerged disease since 2013. Starting from 2014 to 2016 dengue fever outbreak was reported from different part of Ethiopia. Even though the outbreak was reported, the outbreak data was not well documented and recorded, which is very significant for the epidemiological and health information provision as a cornerstone for the health care systems to make possible preventive and curative measures for the coming dengue fever outbreak. An early diagnosis of dengue infection is very important in the management of the disease. Ethiopia, thrive the scope of the existing Malaria Control Program to include Vector-Borne Diseases; initiate dengue and other arboviral diseases surveillance by establishing sentinel sites at health centers and hospitals in the most affected areas of Dire Dawa, Afar and Somali Regions. There is no specific antibiotic (drug) for the treatment dengue fever. Dengvaxia® (CYD-TDV), was the first dengue vaccine, developed by Sanofi and has now been approved by regulatory authorities in 20 countries for use in endemic settings in persons ranging from 9-45 years of age. For dengue fever and sever dengue fever, an experienced physicians and nurses who can give medical care with the effects and progression of the disease can decreasing mortality rates and save lives.

Keywords:Dengue Fever; Dengue Epidemiology; Pathogenesis; Vector; Ethiopia

References

1. “Dengue and severe dengue”. September (2018).
2. “Global Strategy for Dengue Prevention and Control 2012 - 2020”. WHO, Geneva, Switzerland, (2012).
3. Kyle JL and Harris E. “Global spread and persistence of dengue”. Annual Review of Microbiology 62 (2008): 71-92.
4. Wilder-Smith A., et al. “Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development”. Current Infectious Disease Reports 3 (2010): 157-164.
5. Gubler DJ. “The economic burden of dengue”. American Journal of Tropical Medicine and Hygiene 5 (2012): 743-744.
6. Halstead Scott B. “Dengue”. London: Imperial College Press, (2008): 180-429.
7. Abdallah TM., et al. “Epidemiology of dengue infections in Kassala, Eastern Sudan”. Journal of Medical Virology3 (2012): 500-503.
8. Malik A., et al. “Dengue hemorrhagic fever outbreak in children in Port Sudan”. Journal of Infection and Public Health 1? (2011): 1-6.
9. “Dengue Guidelines for Diagnosis, Treatment, Prevention and Control (PDF)”. Geneva: World Health Organization (2009).
10. Amarasinghe A., et al. “Dengue Virus Infection in Africa”. Emerging Infectious Diseases 8 (2011): 1349-1354.
11. Guillena J B., et al. “Prevalence of dengue fever (DF) and dengue hemorrhagic fever (DHF): a description and forecasting”. in Proceedings of the 11th National Convention on Statistics (NCS ’10) (2010): 16.
12. Messina JP., et al. “Global spread of dengue virus types: mapping the 70 year history”. Trends in Microbiology 3 (2014): 138-146.
13. Guzman MG., et al. “Dengue: a continuing global threat". Nature Reviews Microbiology 8 (2010): S7-16.
14. Cameron P Simmons., et al. “Dengue: Current concepts (Review article)”. The New England Journal of Medicine 15 (2012): 1423-1432.
15. Van Kleef E., et al. “Review: The geographic distribution of dengue fever and the potential influence of global climate change”. (2009).
16. Morin CW., et al. “Climate and dengue transmission: Evidence and implications”. Environmental Health Perspectives11,12 (2013).
17. Whitehorn J and Farrar J. "Dengue". British Medical Bulletin 95 (2010): 161-173.
18. Kularatne SA. "Dengue fever". BMJ 351 (2015): h4661.
19. M Mekonnen and H Kloos. “Yellow fever and other arboviral diseases”. in Epidemiology and Ecology of Health and Disease in Ethiopia, Y. Berhane, D.H. Mariam, and H. Kloos, Eds., pp. 635- 645, Shema Books, Addis Ababa, Ethiopia (2006).
20. Dejene Getachew., et al. “Breeding Sites of Aedes aegypti: Potential Dengue Vectors in Dire Dawa, East Ethiopia”. Interdisciplinary Perspectives on Infectious Diseases (2015).
21. Getachew Ferede., et al. “A serologic study of dengue in northwest Ethiopia: Suggesting preventive and control measures”. PLOS Neglected Tropical Diseases5 (2018): e0006430.
22. Were F. “The dengue situation in Africa”. Paediatrics and International Child Health 32 (2012): 18-21.
23. Centers for Disease Control and Prevention. “National Center for Emerging and Zoonotic Infectious Diseases (NCEZID); Division of Vector-Borne Diseases (DVBD)”. (2014): 888-232-634.
24. , et al. “Evidence-based risk assessment and communication: a new global dengue-risk map for travelers and clinicians”. Journal of Travel Medicine 23.6 (2016).
25. Platt KB., et al. “Impact of dengue virus infection on feeding behavior of Aedes aegypti”. American Journal of Tropical Medicine and Hygiene2 (1997): 119-125.
26. Simmons CP., et al. “Dengue". The New England Journal of Medicine15 (2012): 1423-1432.
27. Malavige GN., et al. “Dengue viral infections”. Postgraduate Medical Journal 80 (2004): 588-601.
28. Yacoub S and Wills B. "Predicting outcome from dengue". BMC Medicine1 (2014): 147.
29. Alcon-LePoder S., et al. “Secretion of flaviviral non-structural protein NS1: From diagnosis to pathogenesis”. Novartis Foundation Symposia 277 (2006): 233-247.
30. New CDC test for dengue approved. Centers for Disease Control and Prevention (2012).
31. Chen LH and Wilson ME. "Dengue and chikungunya infections in travellers". Current Opinion in Infectious Diseases 5 (2010): 43844.
32. Center for Disease Control and Prevention. "Chapter 5 - dengue fever (DF) and dengue hemorrhagic fever (DHF)". Yellow Book (2010).
33. Brady OJ., et al. “Refining theglobal spatial limits of dengue virus transmission by evidence-based consensus”. PLOS Neglected Tropical Diseases 6 (2012): e1760.
34. Bekele Woyessa., et al. “The first acute febrile illness investigation associated with dengue fever in Ethiopia”. Journal of Health Development3 (2014): 155-161.

Citation

Citation: Abas Mahammed., et al. “Dengue Fever Epidemiology, Pathogenesis, Prevention and Control in Ethiopia". Acta Scientific Microbiology 5.6 (2022): 34-44.

Copyright

Copyright: © 2022 Abas Mahammed., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.